According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...

The use of microarrays to analyse gene expression on a global level has recently received a great deal of attention. There has been much speculation about the power of this approach in the analysis of ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...

Genomics has the potential to revolutionize the diagnosis and management of cancer by offering an unprecedented comprehensive view of the molecular underpinnings of pathology. Computational analysis ...

The global biomarkers market is projected to grow to $112.1b by 2031, from $67.95b in 2026, due to expanding use in drug ...